Showing results (161-170 of 7,627) with videos related to
Sort By:
Pageof 763
American Journal of Hematology|September 17, 2011
Annual clinical updates in hematological malignancies: a continuing medical education series. Hodgkin lymphoma: 2011 update on diagnosis, risk-stratification, and managementStephen M AnsellAmerican Journal of Hematology|September 8, 2011
Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemiaDjordje Atanackovic, Tim Luetkens, Benjamin Kloth, et al.American Journal of Hematology|September 8, 2011
Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B-cell lymphomaMichele Pohlen, Hans U Gerth, Ruediger Liersch, et al.American Journal of Hematology|August 1, 1990
Recent progress in the molecular genetic analysis of erythroenzymopathyH Fujii, S MiwaAmerican Journal of Hematology|June 2, 2011
A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myelomaIrene M Ghobrial, Nikhil C Munshi, Brianna N Harris, et al.American Journal of Hematology|June 2, 2011
Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trialShaji K Kumar, Martha Q Lacy, Suzanne R Hayman, et al.American Journal of Hematology|June 2, 2011
A prognostic model for short term adverse events in normotensive patients with pulmonary embolismMariette J Agterof, Roger E G Schutgens, Noureddine Moumli, et al.American Journal of Hematology|June 2, 2011
Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesisGiuseppe Gritti, Agostino Cortelezzi, Paolo Bucciarelli, et al.American Journal of Hematology|September 1, 1990
Discordance between phenotype and function of Japanese adult T cell leukemia cellsN Imamura, D M Mtasiwa, H Ota, et al.American Journal of Hematology|March 29, 2011
Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemiaSu Jin Lee, Chul Won Jung, Dae-Young Kim, et al.Pageof 763